Zwischen Autoimmunität und Tauopathie: die Anti-IgLON5-Erkrankung
Authors:
Open Access
- 22 December 2025
- journal article
- im fokus
- Published by Springer Nature in DGNeurologie
- Vol. 9 (1) , 5-13
Abstract
No abstract availableFunding Information
- Ruhr-Universität Bochum
This publication has 28 references indexed in Scilit:
- Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseJAMA Neurology, 2025
- Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohortJournal of Neurology, 2025
- Patterns of Tau pathology in patients with anti-IgLON5 disease visualized by Florzolotau (18F) PETJournal of Neurology, 2025
- Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyActa Neuropathologica, 2024
- Clinical presentations and antibody mechanisms in anti-IgLON5 diseaseRevue Neurologique, 2024
- Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 diseaseActa Neuropathologica, 2023
- Motor-neuron-disease-like phenotype associated with IgLON5 diseaseJournal of Neurology, 2022
- Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and NeurodegenerationAnnals of Neurology, 2020
- Corticobasal Syndrome in a Patient with Anti‐IgLON5 AntibodiesMovement Disorders Clinical Practice, 2020
- IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neuronsCell Biochemistry and Function, 2009